In the News
powered by Ovast-
FDA Panel Backs New Obesity Drug
wsj.com 2 weeks, 3 days agoA Food and Drug Administration advisory committee recommended the agency approve an Arena Pharmaceuticals drug to treat obesity, the second time this year advisers have backed a fat-fighting medication.
-
Pom Tests Limits Of FTC Power With Ad Campaign
washingtonpost.com 2 days, 11 hours agoThe juice maker Pom poked a big stick in the eye of the Federal Trade Commission this week. The FTC and the marketer of pomegranate juice have been locked in a legal battle since the agency accused the company of over-hyping the health benefits of its juice and related products. Earlier this week, an administrative court judge slammed Pom for failing to back up claims in some of its advertisements, specifically about the products’ ability to treat or prevent heart disease, prostate cancer and erectile dysfu


















Loading More Stories